Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed
- PMID: 21971285
- PMCID: PMC3544157
- DOI: 10.1038/nrrheum.2011.152
Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed
Abstract
Systemic sclerosis is associated with a high level of patient mortality. A promising prognostic model that could enable more effective management and improve survival was recently validated; however, the results demonstrate that choosing the best cohorts for development and validation of predictors of mortality is essential.
Similar articles
-
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort.J Rheumatol. 2010 Nov;37(11):2422-6. doi: 10.3899/jrheum.100001. Epub 2010 Sep 15. J Rheumatol. 2010. PMID: 20843905
-
Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.Int J Cardiol. 2017 Jun 1;236:432-437. doi: 10.1016/j.ijcard.2017.01.097. Epub 2017 Jan 18. Int J Cardiol. 2017. PMID: 28159359
-
[Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].Hautarzt. 1998 Jul;49(7):545-51. doi: 10.1007/s001050050786. Hautarzt. 1998. PMID: 9715381 Review. German.
-
Models for prediction of death in systemic sclerosis: current perspectives and future directions.Expert Rev Clin Immunol. 2011 Jul;7(4):391-3. doi: 10.1586/eci.11.33. Expert Rev Clin Immunol. 2011. PMID: 21790278 No abstract available.
-
Interstitial lung disease in systemic sclerosis: current and future treatment.Rheumatol Int. 2017 Jun;37(6):853-863. doi: 10.1007/s00296-016-3636-7. Epub 2017 Jan 6. Rheumatol Int. 2017. PMID: 28063071 Review.
Cited by
-
Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis.J Blood Med. 2021 Nov 9;12:951-964. doi: 10.2147/JBM.S338077. eCollection 2021. J Blood Med. 2021. PMID: 34785969 Free PMC article. Review.
-
[Autologous stem cell transplantation in systemic sclerosis].Z Rheumatol. 2016 Oct;75(8):762-769. doi: 10.1007/s00393-016-0168-1. Z Rheumatol. 2016. PMID: 27510996 Review. German.
-
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?Bone Marrow Transplant. 2016 Apr;51(4):501-5. doi: 10.1038/bmt.2015.299. Epub 2015 Dec 7. Bone Marrow Transplant. 2016. PMID: 26642332 Clinical Trial.
References
-
- Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin. Arthritis Rheum. 2010;39:269–277. - PubMed
-
- Nihtyanova S, et al. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM. 2010;103:109–115. - PubMed
-
- Fransen J, et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann. Rheum. Dis. 2011;70:1788–1792. - PubMed
-
- Bryan C, Howard Y, Brennan P, Black C, Silman A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br. J Rheumatol. 1996;35:1122–1126. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical